What medical treatments are available for male infertility, and when are they recommended?

Medical treatment for male infertility depends on the underlying cause identified during fertility assessment. Because male infertility can result from a range of biological conditions, including hormonal disorders, varicocele, infections, genetic abnormalities, and systemic diseases, treatment is tailored to address the specific diagnosis rather than applying a single approach to all patients. Men who have been unable to conceive after 12 months of regular unprotected intercourse, or after 6 months when the female partner is aged 35 years or older, should undergo fertility assessment to identify potentially treatable causes.

Hormonal disorders affecting the hypothalamic–pituitary–gonadal axis may be treated with hormone therapy to restore normal spermatogenesis, while infections or inflammatory conditions are managed with targeted antimicrobial or anti-inflammatory treatment where appropriate. Men with a clinically significant varicocele may benefit from surgical repair (varicocelectomy), which can improve sperm quality and reduce sperm DNA fragmentation (Gill et al., 2021). In cases where irreversible biological factors such as genetic abnormalities or severe testicular dysfunction are present, medical treatment may have limited benefit, and assisted reproductive technologies (ART) may be recommended instead. Alongside medical treatment, lifestyle optimisation, including weight management, smoking cessation, limiting alcohol intake, and reducing exposure to environmental toxins, can help reduce oxidative stress and support overall sperm health (Vaughan et al., 2020; Petersen et al., 2018).

Gill, K., Jakubik-Uljasz, J., Kups, M., & Kurpisz, M. (2021). The impact of varicocele on sperm DNA integrity and male fertility. International Journal of Molecular Sciences, 22(6), 1–16.

Petersen, C. G., Mauri, A. L., Vagnini, L. D., Renzi, A., Petersen, B., Mattila, M., & Franco, J. G. Jr. (2018). The effects of male age on sperm DNA damage. Reproductive Biology and Endocrinology, 16(1), 1–10.

Vaughan, D. A., Tirado, E., Garcia, D., Datta, V., & Toth, T. L. (2020). Sperm DNA fragmentation and male age: a systematic review. Journal of Assisted Reproduction and Genetics, 37(1), 19–26.

Can hormone therapy improve sperm count and fertility outcomes?

Hormone therapy can improve sperm production and fertility outcomes when infertility is caused by an underlying hormonal imbalance. Disorders affecting the hypothalamic–pituitary–gonadal axis may disrupt the hormones required for normal spermatogenesis, leading to reduced sperm quantity and quality. In these cases, medical treatment aimed at restoring normal hormone levels may improve sperm production and increase the likelihood of conception.

However, hormone therapy is not effective for all causes of male infertility. Men with normal hormone levels, genetic abnormalities, or structural defects affecting sperm production or transport are unlikely to benefit from hormonal treatment alone. Fertility specialists therefore perform hormonal evaluation before initiating therapy to ensure that treatment targets an identifiable endocrine abnormality rather than empirically prescribing hormones.

How are conditions such as varicocele, infections, or hormonal imbalances treated to improve male fertility?

Treatment of these conditions aims to address the underlying cause of impaired sperm production and reduce factors that contribute to sperm DNA damage. A varicocele, characterised by enlarged veins within the scrotum, can impair testicular function by increasing testicular temperature and oxidative stress. Surgical repair (varicocelectomy) may improve semen quality and reduce sperm DNA fragmentation, although improvements are generally not seen immediately because a complete cycle of spermatogenesis takes approximately three months (Gill et al., 2021).

Infections and inflammatory conditions of the reproductive tract are typically treated with targeted antimicrobial therapy when indicated. Where infection or inflammation is suspected, microbiological testing may be performed to identify the causative organism and guide treatment. Follow-up testing may also be recommended to confirm resolution of the infection and assess whether sperm quality has improved. Hormonal disorders are managed according to the specific endocrine abnormality, with hormone therapy used to restore normal spermatogenesis where appropriate. Together with treatment of these medical conditions, reducing modifiable contributors to oxidative stress, such as smoking, obesity, and environmental toxin exposure, may further improve sperm quality (Gallegos et al., 2008; Vaughan et al., 2020).

Gill, K., Jakubik-Uljasz, J., Kups, M., & Kurpisz, M. (2021). The impact of varicocele on sperm DNA integrity and male fertility. International Journal of Molecular Sciences, 22(6), 1–16.

Vaughan, D. A., Tirado, E., Garcia, D., Datta, V., & Toth, T. L. (2020). Sperm DNA fragmentation and male age: a systematic review. Journal of Assisted Reproduction and Genetics, 37(1), 19–26.

Gallegos, G., Ramos, B., Santiso, R., Goyanes, V., Gosálvez, J., Fernández, J. L., & Garrido, N. (2008). Sperm DNA fragmentation in infertile men with genitourinary infection. Fertility and Sterility, 90(2), 328–334.